CEL-SCI Corporation reported financial results for the fiscal year ended September 30, 2024, as well as key clinical and corporate developments. "We are very optimistic about the prospects of our ...

Think salmon, mackerel, sardines, or any other option that is naturally oily. These fish are packed with omega-3 fatty acids, ...

Treatment with risankizumab following inadequate response to secukinumab or ixekizumab was associated with improved disease severity, quality of life, and symptoms among patients with plaque psoriasis ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ...